Skip to main content

Cody Keetch


[email protected]



Cody focuses his practice on health care transactions and advises health care organizations on regulatory, compliance, and governance matters. He regularly negotiates and drafts documents for mergers, acquisitions, and reorganizations. Cody assists clients with formation and dissolution, governance disclosures to state regulatory bodies, employment agreements, and licensure and certification applications. His practice involves preparing a wide variety of corporate and commercial agreements, including license and service agreements. In addition, Cody represents clients in the technology and life sciences industries.

Prior to joining Mintz, Cody was an associate at a Long Island, New York–based boutique law firm that serves the health care industry, where he handled transactional, corporate, and compliance matters.

While attending law school, Cody had a number of internships and externships focusing on legal issues affecting the health care sector, including with the Health Care Bureau of the New York State Attorney General’s Office and the Centers for Disease Control and Prevention in Atlanta,  researching and drafting pleadings, motions, and memorandums on health law and other legal issues. Cody also worked as a legal extern at the American Cancer Society in Atlanta and a legal intern at the Children's Cancer & Blood Foundation in New York, where he focused on contracting and corporate governance matters.

Cody participated in the Transactional Law Certificate Program at Emory University School of Law.


  • Emory University (JD)
  • University of Michigan (BA)


- Spanish


Health Care Viewpoints Thumbnail

The American Families Plan & A Call for Drug Pricing Legislation

May 10, 2021 | Blog | By Theresa Carnegie, Cody Keetch

On April 28, 2021, President Biden gave his first address to Congress and announced the American Families Plan (AFP). The AFP follows the 1.9 trillion-dollar stimulus, the American Rescue Plan Act, signed into law on March 11, 2021. Notably, in his speech, President Biden called upon Congress to pass drug pricing legislation; however, the current White House Fact Sheet on the AFP does not include specific drug pricing provisions. This blog post discusses the health-related portions of the AFP and provides an overview of the Lower Drug Costs Now Act which seeks to lower prescription drug prices.
Read more